D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 95 Citations 44,606 320 World Ranking 4772 National Ranking 446

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

His main research concerns Internal medicine, Vasculitis, Surgery, Gastroenterology and Systemic vasculitis. His study in Cyclophosphamide, Rheumatology, Rheumatism, Rituximab and Lupus nephritis is carried out as part of his studies in Internal medicine. His work deals with themes such as Antibody, Immunology and Intensive care medicine, which intersect with Vasculitis.

His Gastroenterology research includes elements of Creatinine, Placebo and Azathioprine. His work in Systemic vasculitis covers topics such as Retrospective cohort study which are related to areas like Polyarteritis nodosa. His research investigates the connection between Anti-neutrophil cytoplasmic antibody and topics such as Microscopic polyangiitis that intersect with problems in Granulomatosis with polyangiitis.

His most cited work include:

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides (2901 citations)
  • A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies (1073 citations)
  • Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis (1036 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Vasculitis, Immunology, Rituximab and Gastroenterology. His research investigates the connection between Internal medicine and topics such as Surgery that intersect with issues in Adverse effect. Vasculitis is a primary field of his research addressed under Pathology.

The various areas that David Jayne examines in his Immunology study include Lupus nephritis, Disease and Clinical trial. His studies in Rituximab integrate themes in fields like Hypogammaglobulinemia, Autoimmune disease and Prednisone. His work carried out in the field of Gastroenterology brings together such families of science as Creatinine, Kidney and Renal function.

He most often published in these fields:

  • Internal medicine (53.52%)
  • Vasculitis (48.46%)
  • Immunology (29.74%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (53.52%)
  • Vasculitis (48.46%)
  • Rituximab (21.59%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Vasculitis, Rituximab, Granulomatosis with polyangiitis and Microscopic polyangiitis. His Internal medicine study frequently draws connections to other fields, such as Gastroenterology. His Vasculitis study combines topics from a wide range of disciplines, such as Cyclophosphamide and Immunology.

His Rituximab research is multidisciplinary, relying on both Prednisolone, Hypogammaglobulinemia, Azathioprine, Prednisone and Dosing. David Jayne works mostly in the field of Granulomatosis with polyangiitis, limiting it down to concerns involving Eosinophilic and, occasionally, Myeloperoxidase and Proteinase 3. His Systemic vasculitis study which covers Regimen that intersects with Prospective cohort study.

Between 2019 and 2021, his most popular works were:

  • Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis (90 citations)
  • 2019 Update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis (67 citations)
  • ANCA-associated vasculitis. (24 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

David Jayne focuses on Internal medicine, Vasculitis, Rituximab, Microscopic polyangiitis and Granulomatosis with polyangiitis. His study ties his expertise on Gastroenterology together with the subject of Internal medicine. His Vasculitis study frequently draws parallels with other fields, such as Immunology.

The Rituximab study combines topics in areas such as Maintenance therapy, Azathioprine, ANCA-Associated Vasculitis and Cyclophosphamide. His Microscopic polyangiitis research incorporates themes from Alternative complement pathway, Complement factor B, Complement system, Anti-neutrophil cytoplasmic antibody and Systemic vasculitis. His Granulomatosis with polyangiitis research is multidisciplinary, incorporating perspectives in Mononeuritis Multiplex, Polyarthritis, Asthma, Properdin and Complement membrane attack complex.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

J. C. Jennette;R. J. Falk;P. A. Bacon;N. Basu.
Arthritis & Rheumatism (2013)

2901 Citations

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel B. Jones;Jan Willem Cohen Tervaert;Thomas Hauser;Raashid Luqmani.
The New England Journal of Medicine (2010)

1513 Citations

A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

David Jayne;Niels Rasmussen;Konrad Andrassy;Paul Bacon.
The New England Journal of Medicine (2003)

1492 Citations

EULAR Recommendations for the management of primary small and medium vessel vasculitis

C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta.
Annals of the Rheumatic Diseases (2009)

1312 Citations

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis

David R.W. Jayne;Gill Gaskin;Niels Rasmussen;Daniel Abramowicz.
Journal of The American Society of Nephrology (2007)

1098 Citations

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler.
Journal of The American Society of Nephrology (2009)

1059 Citations

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

George K Bertsias;Maria Tektonidou;Zahir Amoura;Martin Aringer.
Annals of the Rheumatic Diseases (2012)

1012 Citations

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis

Kirsten De Groot;Niels Rasmussen;Paul A Bacon;Jan Willem Cohen Tervaert.
Arthritis & Rheumatism (2005)

832 Citations

Genetically Distinct Subsets within ANCA-Associated Vasculitis

Paul A Lyons;Tim F Rayner;Sapna Trivedi;Julia U Holle.
The New England Journal of Medicine (2012)

796 Citations

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

Kirsten de Groot;Lorraine Harper;David R.W. Jayne;Luis Felipe Flores Suarez.
Annals of Internal Medicine (2009)

794 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David Jayne

Loïc Guillevin

Loïc Guillevin

Université Paris Cité

Publications: 202

Ulrich Specks

Ulrich Specks

Mayo Clinic

Publications: 124

Luc Mouthon

Luc Mouthon

Université Paris Cité

Publications: 99

Charles D. Pusey

Charles D. Pusey

Imperial College London

Publications: 99

Xavier Puéchal

Xavier Puéchal

Université Paris Cité

Publications: 96

John H. Stone

John H. Stone

Harvard University

Publications: 89

Yehuda Shoenfeld

Yehuda Shoenfeld

Sheba Medical Center

Publications: 85

Wolfgang L. Gross

Wolfgang L. Gross

University of Lübeck

Publications: 79

Alfred Mahr

Alfred Mahr

Université Paris Cité

Publications: 78

Jan Willem Cohen Tervaert

Jan Willem Cohen Tervaert

University of Alberta

Publications: 77

David A. Isenberg

David A. Isenberg

University College London

Publications: 76

Ronald J. Falk

Ronald J. Falk

University of North Carolina at Chapel Hill

Publications: 76

Gary S. Hoffman

Gary S. Hoffman

Cleveland Clinic

Publications: 73

Dimitrios T. Boumpas

Dimitrios T. Boumpas

National and Kapodistrian University of Athens

Publications: 70

Coen A. Stegeman

Coen A. Stegeman

University Medical Center Groningen

Publications: 69

Alan D. Salama

Alan D. Salama

University College London

Publications: 69

Trending Scientists

Stephen Lin

Stephen Lin

Microsoft (United States)

Hsien-Hsin S. Lee

Hsien-Hsin S. Lee

Facebook (United States)

Chi Bun Ching

Chi Bun Ching

National University of Singapore

Werner Ens

Werner Ens

University of Manitoba

Wei Qi

Wei Qi

Tianjin University

Zhengwei Pan

Zhengwei Pan

King Fahd University of Petroleum and Minerals

Stephen M. Cohen

Stephen M. Cohen

University of Copenhagen

Margaret M. Mayfield

Margaret M. Mayfield

University of Queensland

Brendan J. M. Bohannan

Brendan J. M. Bohannan

University of Oregon

John Bwalya Muma

John Bwalya Muma

University of Zambia

Skorn Mongkolsuk

Skorn Mongkolsuk

Mahidol University

Mya Breitbart

Mya Breitbart

University of South Florida

John P. Platt

John P. Platt

University of Southern California

Jennifer A. Clack

Jennifer A. Clack

University of Cambridge

Jeanne M. Tschann

Jeanne M. Tschann

University of California, San Francisco

Daniel N. Allen

Daniel N. Allen

University of Nevada, Las Vegas

Something went wrong. Please try again later.